MedTrace Logo

Mono Antiplatelet and Colchicine Therapy

NCT04949516 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-01-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of aspirin-free, P2Y12 inhibitor single antiplatelet and colchicine treatment in patients with acute coronary syndrome treated with drug-eluting stents.

Conditions

  • Acute Coronary Syndrome
  • Drug-Eluting Stents

Interventions

DRUG

Aspirin

Aspirin is discontinued the day after drug-eluting stent implantation

DRUG

Colchicine

Colchicine is started the day after drug-eluting stent implantation

Sponsors & Collaborators

  • Wonkwang University Hospital

    lead OTHER

Principal Investigators

  • Seung-Yul Lee, MD · Wonkwang University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949516 on ClinicalTrials.gov